Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
Who is this study for? Patients with stage 2, 3 or 4 melanoma treated with an ICI
What treatments are being studied? Atorvastatin Calcium
Status: Recruiting
Location: See all (12) locations...
Study Type: Observational
SUMMARY
This study is a prospective observational study evaluating the natural history of coronary plaque burden in participants with melanoma treated with ICI. The study will be conducted at various sites across Australia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:
• Capable of providing informed consent and willing to adhere to all protocol requirements
• patients aged \> or equal to 40 years
• Histologically confirmed melanoma of any stage planned for, commenced, or completed treatment with ICI
• having acceptable imaging quality deemed by the core laboratory
• Investigator believes that the participant is willing to adhere to all protocol requirements, including returning for follow up CTCA.
Locations
Other Locations
Australia
Bundaberg Base Hospital
RECRUITING
Bundaberg
Monash Health
RECRUITING
Clayton
Peninsula Health
RECRUITING
Frankston
Hervey Bay Hospital
RECRUITING
Hervey Bay
Ipswich Hospital
RECRUITING
Ipswich
Nepean Hospital
RECRUITING
Kingswood
Cabrini Health
RECRUITING
Malvern
Peter MacCallum Cancer Centre
RECRUITING
Melbourne
Mildura Public Base Hospital
RECRUITING
Mildura
Toowoomba Hospital
RECRUITING
Toowoomba
Calvary Mater Newcastle
RECRUITING
Waratah
Queen Elizabeth Hospital
RECRUITING
Woodville South
Contact Information
Primary
Domenic Sacca
domenic.sacca@monash.edu
+61 (0) 423245187
Time Frame
Start Date: 2022-11-07
Estimated Completion Date: 2026-06
Participants
Target number of participants: 130
Authors
Related Therapeutic Areas
Sponsors
Leads: Monash University
Collaborators: National Health and Medical Research Council, Australia